“Due to significant reductions in demand for these products, the company has decided to cease operations at the plant,” the ...
On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...
Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback